Acumen Historical Cash Flow

ABOS Stock  USD 1.65  0.04  2.48%   
Analysis of Acumen Pharmaceuticals cash flow over time is an excellent tool to project Acumen Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 7.4 M or Change In Working Capital of 4.7 M as it is a great indicator of Acumen Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Acumen Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Acumen Pharmaceuticals is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.

About Acumen Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Acumen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Acumen's non-liquid assets can be easily converted into cash.

Acumen Pharmaceuticals Cash Flow Chart

At this time, Acumen Pharmaceuticals' Stock Based Compensation is comparatively stable compared to the past year. Change In Working Capital is likely to gain to about 4.7 M in 2025, despite the fact that Change In Cash is likely to grow to (53.8 M).

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Change In Working Capital

The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Acumen Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Acumen Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Acumen Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Acumen Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.At this time, Acumen Pharmaceuticals' Stock Based Compensation is comparatively stable compared to the past year. Change In Working Capital is likely to gain to about 4.7 M in 2025, despite the fact that Change In Cash is likely to grow to (53.8 M).
 2022 2024 2025 (projected)
Sale Purchase Of Stock3.9M3.5M3.3M
Change To Liabilities2.6M2.9M3.1M

Acumen Pharmaceuticals cash flow statement Correlations

-0.06-0.130.75-0.830.690.810.750.310.17-1.00.670.76-0.770.90.370.81-0.75-0.76-0.75
-0.060.46-0.380.12-0.12-0.16-0.170.020.940.03-0.13-0.420.090.220.0-0.130.060.070.06
-0.130.46-0.720.57-0.73-0.6-0.690.650.260.1-0.75-0.04-0.080.060.6-0.620.660.660.66
0.75-0.38-0.72-0.950.950.970.97-0.09-0.08-0.720.950.61-0.580.62-0.010.96-0.94-0.94-0.94
-0.830.120.57-0.95-0.95-0.98-0.97-0.03-0.170.81-0.94-0.630.69-0.78-0.11-0.980.970.970.97
0.69-0.12-0.730.95-0.950.970.99-0.220.2-0.661.00.41-0.470.63-0.150.98-0.99-0.99-0.99
0.81-0.16-0.60.97-0.980.970.99-0.010.15-0.790.960.6-0.650.760.071.0-0.98-0.98-0.98
0.75-0.17-0.690.97-0.970.990.99-0.160.15-0.730.990.49-0.530.67-0.080.99-0.99-0.99-0.99
0.310.020.65-0.09-0.03-0.22-0.01-0.16-0.03-0.33-0.270.66-0.750.51.0-0.070.160.160.16
0.170.940.26-0.08-0.170.20.150.15-0.03-0.190.18-0.29-0.070.44-0.020.19-0.24-0.24-0.24
-1.00.030.1-0.720.81-0.66-0.79-0.73-0.33-0.19-0.65-0.750.77-0.9-0.39-0.790.740.740.74
0.67-0.13-0.750.95-0.941.00.960.99-0.270.18-0.650.38-0.430.6-0.190.97-0.99-0.99-0.99
0.76-0.42-0.040.61-0.630.410.60.490.66-0.29-0.750.38-0.90.70.710.55-0.46-0.46-0.46
-0.770.09-0.08-0.580.69-0.47-0.65-0.53-0.75-0.070.77-0.43-0.9-0.88-0.8-0.60.530.530.53
0.90.220.060.62-0.780.630.760.670.50.44-0.90.60.7-0.880.560.75-0.7-0.7-0.7
0.370.00.6-0.01-0.11-0.150.07-0.081.0-0.02-0.39-0.190.71-0.80.560.010.080.080.08
0.81-0.13-0.620.96-0.980.981.00.99-0.070.19-0.790.970.55-0.60.750.01-0.99-0.99-0.99
-0.750.060.66-0.940.97-0.99-0.98-0.990.16-0.240.74-0.99-0.460.53-0.70.08-0.991.01.0
-0.760.070.66-0.940.97-0.99-0.98-0.990.16-0.240.74-0.99-0.460.53-0.70.08-0.991.01.0
-0.750.060.66-0.940.97-0.99-0.98-0.990.16-0.240.74-0.99-0.460.53-0.70.08-0.991.01.0
Click cells to compare fundamentals

Acumen Pharmaceuticals Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Acumen Stock Analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.